BioRem Inc. (CVE:BRM) Director Sells C$351,600.00 in Stock

BioRem Inc. (CVE:BRMGet Free Report) Director Derek Webb sold 120,000 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00.

BioRem Stock Performance

Shares of BioRem stock opened at C$2.97 on Wednesday. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08. The firm has a market cap of C$46.63 million, a price-to-earnings ratio of 14.14 and a beta of 0.85. BioRem Inc. has a one year low of C$0.88 and a one year high of C$3.39. The stock’s 50-day moving average is C$2.68 and its 200-day moving average is C$2.32.

BioRem Company Profile

(Get Free Report)

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.

Recommended Stories

Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.